PDL BioPharma

PDL BioPharma, Inc. has named Andrew Guggenhime senior vice president and chief financial officer. Mr. Guggenhime will join the company’s senior management team reporting directly to chief executive officer Mark McDade, and will be responsible for all financial and information technology operations of the company.

Mr. Guggenhime joins the company from Neoforma, Inc. where he had been chief financial officer since October 2000. In this role, he was responsible for the accounting, finance, financial planning and analysis, investor relations, legal and facilities departments. He was previously vice president of corporate development, managing Neoforma’s corporate development, business development, international and strategic efforts. Prior to joining Neoforma, he was a vice president in the Healthcare Investment Banking group of Merrill Lynch & Co., where he specialized in working with healthcare services firms and healthcare Internet companies on a variety of transactions, including mergers and acquisitions, initial public offerings, add-on equity offerings and debt offerings. Previously, he worked at Wells Fargo & Company in a number of capacities.